Calidi Biotherapeutics
CLDI
CLDI
24 hedge funds and large institutions have $40.6M invested in Calidi Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2.26M
Holders
24
Holding in Top 10
–
Calls
–
Puts
$2.26M
Top Buyers
| 1 | +$2.24M | |
| 2 | +$1.68M | |
| 3 | +$1.3M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$461K |
| 5 |
ASM
ATW SPAC Management
New York
|
+$441K |
Top Sellers
| 1 | -$3.85M | |
| 2 | -$2.05M | |
| 3 | -$684K | |
| 4 |
VF
Virtu Financial
New York
|
-$312K |
| 5 |
E
Ergoteles
New York
|
-$196K |